Perceptive Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $25.2M | Sell |
|
|||||
|
2022
Q1 | $29.4M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $18.5M | Sell |
|
|||||
|
2018
Q3 | $105M | Sell |
|
|||||
|
2018
Q2 | $182M | Buy |
|
|||||
|
2018
Q1 | $153M | Sell |
|
|||||
|
2017
Q4 | $169M | Sell |
|
|||||
|
2017
Q3 | $210M | Sell |
|
|||||
|
2017
Q2 | $146M | Buy |
|
|||||
|
2017
Q1 | $56.6M | Buy |
|
|||||
|
2016
Q4 | $4.44M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $3.36M | Buy |
|